Pharmaceutical Advertising Advisory Board

Pharma Leader Dr. Holger Zimmermann Joins Lysando's Advisory Board in Pioneering Fight Against Antibiotic-Resistant Bacteria

Retrieved on: 
Wednesday, November 8, 2023
Health, Infectious Diseases, Research, Pharmaceutical, Science, Biotechnology, Knowledge, Hope, Antimicrobial resistance, Advisory board, Pharmaceutical Advertising Advisory Board, Development, Multimedia, Pharmaceutical industry, Vaccine

Lysando, a leading innovator in the fight against antibiotic-resistant bacteria, proudly announces the appointment of Dr. Holger Zimmermann to its Advisory Board.

Key Points: 
  • Lysando, a leading innovator in the fight against antibiotic-resistant bacteria, proudly announces the appointment of Dr. Holger Zimmermann to its Advisory Board.
  • His extensive background in human pharmaceutical pre-clinical and clinical research underscores the transformative potential he brings to Lysando.
  • Count Markus Matuschka de Greiffenclau, Chairman of the Board of Directors of Lysando, expresses his enthusiasm, stating, “We are delighted to welcome Dr. Holger Zimmermann to our Advisory Board.
  • Expressing his excitement to join Lysando, Dr. Holger Zimmermann states, “Lysando's Artilysin® technology represents a powerful tool to combat antibiotic-resistant germs.

DIMERx Announces Appointment of Peter Barton Hutt and Harvinder Dhani to its Board of Directors

Retrieved on: 
Tuesday, September 19, 2023
Health, Health Technology, General Health, Research, Science, Pharmaceutical, Biotechnology, Covington & Burling, Doctor of Philosophy, Addiction, Pharmaceutical Advertising Advisory Board, Government, Pain, Patient, Standard of care, Agency, Risk, Investment, Head, Entrepreneurship, FDA, Central Waqf Council, Legislation, Pharmaceutical industry

DIMERx , a leading pioneer of covalent chemistry-based dimer technology, is pleased to announce the appointment of two influential individuals to its Board of Directors: Peter Barton Hutt and Harvinder Dhani.

Key Points: 
  • DIMERx , a leading pioneer of covalent chemistry-based dimer technology, is pleased to announce the appointment of two influential individuals to its Board of Directors: Peter Barton Hutt and Harvinder Dhani.
  • Peter Barton Hutt brings with him a wealth of complex regulatory and pharmaceutical experience amassed over career-spanning decades.
  • Except for his 4 years in the government, Mr. Hutt has continued at the firm for most of his career.
  • I am humbled that DIMERx has asked me to join the Board and I want to see the company succeed.”
    “We are very thrilled to welcome Peter Barton Hutt and Harvinder Dhani to our Board of Directors,” said Nikhilesh Singh, Ph.D., Co-Founder and Chief Executive Officer.

NEW ASSOCIATION LAUNCHED TO PROTECT CASK WHISKY CUSTOMERS AND UPHOLD THE REPUTATION OF THE SCOTCH INDUSTRY

Retrieved on: 
Thursday, September 21, 2023
Insurance, ASA, Worshipful Company of Distillers, Pharmaceutical Advertising Advisory Board, Whisky, Member, City, BWA, Digital marketing, Advisory board, Sale, Competition, Certification, SWA, Scotch Whisky Association, Distiller, CWA, FDI, Livery company, Independent Advisory Board for Senate Appointments, MP, Scotch whisky, Advertising, National Executive Board of the Boy Scouts of America, Letter, Environment, Consumer Bill of Rights, Social media, Harrington, Beer, Liquor, Financial adviser, Scotch

By setting best practices in cask whisky ownership and sale, the Association aims to protect cask whisky customers and the wider whisky industry.

Key Points: 
  • By setting best practices in cask whisky ownership and sale, the Association aims to protect cask whisky customers and the wider whisky industry.
  • Chairman of the Advisory Board and spokesman for the CWA Colin Hampden-White says the Association's goal is to uphold the overall reputation of the Scotch whisky industry.
  • "The Cask Whisky Association exists to protect private customers from unscrupulous business practices and traders and safeguard independent bottlers from over-inflated pricing," Colin says, adding: "Our Members are committed to, and will provide guidance on, best practice."
  • That's why I think certification and licensing is so important; the Cask Whisky Association provides a quality hallmark for people looking to buy and invest in whisky.

SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing as VP of Quality with Immediate Effect

Retrieved on: 
Monday, September 11, 2023
IBN, Pharmaceutical Advertising Advisory Board, Master of Science in Quality Management and Analytics, Kansas State University, Advisory board, CGMP, OTC, Biology, FDA, IND, Microbiology, San Diego State University, Pharmaceutical industry, Science, WM, Quality

Dewey Rushing as a Vice President-Quality with the company.

Key Points: 
  • Dewey Rushing as a Vice President-Quality with the company.
  • Dewey Rushing is a senior compliance remediation and quality professional with more than 30 years of experience in quality assurance and cGMP compliance for FDA-regulated products.
  • SOHM has appointed him as the Vice President of Quality, recognizing his exceptional qualifications and experience in pharmaceutical quality validation and cGMP compliance."
  • Mr. Rushing is a well-known expert in the field of pharmaceutical quality validation and cGMP compliance and has worked with several leading companies in the industry.

JBM Healthcare Announces FY2023 Annual Results

Retrieved on: 
Thursday, June 15, 2023
Health, Marketing, Health care, Policy, COVID-19, Double, Wen Ken Group, Tmall, Government, Pharmaceutical Advertising Advisory Board, JBM, SEASONS, Acquisition, Guangdong–Hong Kong–Macao Greater Bay Area, Growth, Pharmaceutical industry, Retail, Management, PRC

HONG KONG, June 15, 2023 - (ACN Newswire) - JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the annual results of the Group for the year ended 31 March 2023 ("FY2023" or the "Reporting Period").

Key Points: 
  • HONG KONG, June 15, 2023 - (ACN Newswire) - JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the annual results of the Group for the year ended 31 March 2023 ("FY2023" or the "Reporting Period").
  • Including the interim dividend of HK0.5 cent per share already paid, the total dividend for FY2023 would be HK3.0 cents per share.
  • Despite the market challenges posed by COVID-19, JBM Healthcare's portfolio demonstrated resilience during the Reporting Period.
  • Mr. Patrick Wong, Chief Executive Officer of JBM Healthcare, said, "In FY2023, JBM Healthcare demonstrated resilience despite challenges from the fifth wave of the epidemic and external market pressures.

ITM Opens World's Largest Lutetium-177 Production Facility for Targeted Radionuclide Therapies Against Cancer

Retrieved on: 
Tuesday, June 13, 2023
NOVA, ITM, Pharmaceutical Advertising Advisory Board, Therapy, TUM, Radionuclide, FRM, Institute of technology, Radiopharmaceutical, Cancer, Quality of life, Medicine, Research, Advisory board, Minister for Federal Affairs (New South Wales), Vetter Pharma, Nuclear medicine, Free, State Chancellery of Latvia, Patient, Laboratory, Supervisory board, Bavaria, Knowledge, Growth, Health, Munich Airport, Isotope, Automation, IAZ, Technical University of Munich, Pharmaceutical industry, State

ITM’s new facility is the world’s largest production site of lutetium-177, an innovative medical isotope used in targeted cancer therapies.

Key Points: 
  • ITM’s new facility is the world’s largest production site of lutetium-177, an innovative medical isotope used in targeted cancer therapies.
  • Once the new NOVA production facility is fully operational, ITM will increase its capacity to supply clinics, pharmaceutical partners and its own drug pipeline tenfold.
  • The world's largest lutetium-177 production facility for targeted radionuclide therapies against cancer, opened by ITM, is therefore an important milestone - both for the company, the research and production location of Bavaria as a whole and, of course, the patients.
  • “As a local member of parliament, I am particularly pleased that the production facility is being built here in Neufahrn near Freising.

CoinRegTech Announces Shawn Bernardo Joins Advisory Board

Retrieved on: 
Thursday, June 8, 2023
Technology, Other Technology, Advisory board, TP ICAP, Pharmaceutical Advertising Advisory Board, House, TP, Dodd–Frank Wall Street Reform and Consumer Protection Act, Shawn, Cryptocurrency, Financial adviser

CoinRegTech , a leading provider of regulatory technology to the digital asset marketplace, today announced the appointment of Shawn Bernardo to its Advisory Board.

Key Points: 
  • CoinRegTech , a leading provider of regulatory technology to the digital asset marketplace, today announced the appointment of Shawn Bernardo to its Advisory Board.
  • Shawn Bernardo, a reputable figure in the finance industry, serves as the CEO for the Americas of TP ICAP group, the world's largest interdealer broker.
  • “On behalf of the Advisory Board, it is with great pleasure that we welcome Shawn, a highly regarded and influential leader within the sphere of interdealer brokers and clients,” said Bruce Tupper, CoinRegTech President and Founder.
  • It is with eager anticipation that I look forward to joining the adept team at CoinRegTech, as we strive to address the intricate compliance requirements of clients navigating the digital asset markets," said Shawn Bernardo.

Kanabo Group Appoints Ian Mattioli as Chair of the Board and Secures a £2.5M Minimum Investment Round

Retrieved on: 
Tuesday, May 9, 2023
Cannabis, Health, Telemedicine, Virtual Medicine, Health Technology, Natural Resources, General Health, LSE, Chairperson, London Stock Exchange, Pharmaceutical Advertising Advisory Board, Pension, Prescription, Multimedia, Patient, London, Pain management, MBE, NHS, Pharmaceutical industry, Cryptocurrency, Nursing, Kanabō

Kanabo Group (LSE: KNB), a health-tech company focused on patient care with its innovative digital healthcare platform and medical cannabis treatment portfolio, announces Ian Mattioli's appointment as Chair of the Board.

Key Points: 
  • Kanabo Group (LSE: KNB), a health-tech company focused on patient care with its innovative digital healthcare platform and medical cannabis treatment portfolio, announces Ian Mattioli's appointment as Chair of the Board.
  • View the full release here: https://www.businesswire.com/news/home/20230508005630/en/
    Kanabo Group appoints Ian Mattioli, MBE as Non-Executive Chair of the Board (Photo: Business Wire)
    The £2.5M minimum investment round includes an institutional investor, company management, and Ian Mattioli's £500K investment.
  • Ian Mattioli Kanabo Group’s appointed Chair:
    "I am honoured to join Kanabo at this pivotal moment in the company's journey.
  • Kanabo Group Plc (LSE:KNB) is a health-tech company committed to revolutionising patient care through its innovative technology platform and disruptive product offerings.

Candace Matthews Elected Independent Chairperson of Aptar’s Board of Directors

Retrieved on: 
Friday, April 28, 2023
Packaging, Manufacturing, West Pharmaceutical Services, The Coca-Cola Company, Herman Miller, Prologis, Food, BIC, Health, Pharmaceutical Advertising Advisory Board, Kandake, Cosmetics, Multimedia, ATR, Bausch & Lomb, Procter & Gamble, General Mills, AptarGroup, Popeyes, NYSE, Independent, Holding company, Pharmaceutical industry, Novartis, Amway

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced that Candace Matthews has been elected independent chairperson of the company’s Board of Directors, effective immediately following the company’s 2023 annual meeting of stockholders on May 3, 2023.

Key Points: 
  • AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced that Candace Matthews has been elected independent chairperson of the company’s Board of Directors, effective immediately following the company’s 2023 annual meeting of stockholders on May 3, 2023.
  • Candace will succeed George Fotiades, who will remain on the Board of Directors.
  • Candace joined the Aptar Board of Directors in May of 2021.
  • Candace also serves on the Board of Directors for MillerKnoll and Société BIC S.A., and was previously a director for Popeyes Louisiana Kitchen.

SparingVision appoints Joseph C. Papa as Chairman

Retrieved on: 
Wednesday, April 5, 2023
IPO, Actavis, Pharmaceutical Advertising Advisory Board, Bausch, Retinitis pigmentosa, Hope, Bausch Health, Retina, Cardinal Health, Novartis, Patient, Lomb, NYSE, Pharmaceutical industry, Perrigo

Paris, April 5, 2023 – SparingVision, a clinical-stage genomic medicine company developing vision-saving treatments for ocular diseases, today announces the appointment of Joseph C. Papa as its independent Chairman.

Key Points: 
  • Paris, April 5, 2023 – SparingVision, a clinical-stage genomic medicine company developing vision-saving treatments for ocular diseases, today announces the appointment of Joseph C. Papa as its independent Chairman.
  • Papa brings over 30 years of experience in the healthcare sector, having most recently served as Chief Executive Officer and Chairman at Bausch and Lomb Corporation (“Bausch and Lomb”) (NYSE: BLCO) a global eye health company.
  • During his tenure, Papa successfully led the Company's IPO in May 2022 to raise $630 million.
  • Before that, Papa held the role of President and Chief Operating Officer at Watson Pharmaceuticals and worked for 14 years at Novartis Pharmaceuticals in the US and Switzerland.